American Herbal Products Association (AHPA) > About Us > Committees > Cannabis Committee

Cannabis Committee

Chairperson: Asa Waldstein (Supplement Advisory Group)
Staff Contact: Jane Wilson

Committee Purpose: Address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species.

AHPA Members, if you would like to join this committee, please email the staff contact.

Committee Brochure

Committee Resources

Committee Meeting Minutes

November 9, 2020 Meeting Minutes

Meeting of the Cannabis Committee

March 13, 2020 Meeting Minutes

Meeting of the Cannabis Committee

AHPA Members log in to download the meeting minutes.

October 18, 2019 Meeting Minutes

Meeting of the Cannabis Committee

AHPA Members log in to download the meeting minutes.

March 7, 2019 Meeting Minutes

Meeting of the Cannabis Committee

AHPA Members log in to download the meeting minutes.
RSS

Committee-Related News

Supplement and Hemp Industry Associations Applaud Bipartisan Legislation to Regulate Hemp-Derived CBD

September 4, 2020: Bill directs FDA to use its authority and resources to set a clear regulatory framework for hemp and hemp derived CBD

the four leading dietary supplement industry associations applaud Representative Kurt Schrader (D-OR) and Representative Morgan Griffith (R-VA), for introducing bipartisan legislation that would protect public health by providing legal clarity in the cannabidiol (CBD) product marketplace. The Hemp and Hemp derived CBD Consumer Protection and Market Stabilization Act of 2020 directs the U.S. Food and Drug Administration (FDA) to use its authority and resources to set a clear regulatory framework for hemp and hemp derived CBD and assure consumer protection.
AHPA Hemp-CBD Supplement Virtual Congress

AHPA Hemp-CBD Supplement Virtual Congress

On-demand -- Recorded Aug. 27, 2020

AHPA's second, annual Hemp-CBD Supplement Congress was presented on August 27, 2020 and provides companies with an understanding of federal and state legal and regulatory obligations and current issues and opportunities in the hemp-CBD market. This event delivers the latest information to you on-demand.

AHPA Hemp-CBD Status Report

Updated in April 2020 to cover recent FDA and USDA actions

To help the herbal products industry understand the evolving regulatory landscape for hemp and hemp-derived cannabidiol (CBD) products, AHPA has updated its free Hemp-CBD Status Report to include recent actions taken by the Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA).

AOAC Scientists Approve Official Method of Analysis for Cannabinoids in Hemp

April 27, 2020: AHPA Chief Science Officer Dr. Holly Johnson chairs CASP working group involved creating requirements for testing standard

The new validation and approval will allow laboratories to evaluate hemp for tetrahydrocannabinol (THC) on a dry-weight basis, as described by the U.S. Department of Agriculture’s Interim Final Rule governing the production of hemp under the 2018 Agriculture Improvement Act, known as the Farm Bill.

Guidance on California Proposition 65 and Hemp Products

Revised April 2020

In January 2020, Δ9-tetrahydrocannabinol (Δ9 THC) was added to the Proposition 65 list as a chemical known to cause reproductive toxicity. While Δ9 THC is present at only trace levels in hemp products, companies marketing hemp products in California should evaluate whether a warning is needed for these products. Also of concern, are other chemicals on the Proposition 65 list that may be used in the cultivation and processing of hemp and marijuana, such as the pesticides myclobutanil and carbaryl, for which some cannabis businesses have received Proposition 65 notices.

Guidance on California Proposition 65 and Cannabis Products

Revised April 2020

Marijuana smoke was added to the Proposition 65 list in June 2009 as a chemical known to the State of California to cause cancer. In January 2020, cannabis (marijuana) smoke and Δ9-tetrahydrocannabinol (Δ9 THC) were both added to the Proposition 65 list as chemicals known to cause reproductive toxicity. In addition to marijuana smoke and Δ9 THC, other chemicals on the Proposition 65 list that may be used in the cultivation and processing of cannabis, such as the pesticides myclobutanil and carbaryl, must be considered when cannabis businesses are determining compliance to this regulation.
AHPA Cannabis Committee Celebrates a Decade of Industry Leadership

AHPA Cannabis Committee Celebrates a Decade of Industry Leadership

March 10, 2020: For 10 years AHPA’s Cannabis Committee has been actively involved in the regulatory, legislative, and technical aspects of moving cannabis (including hemp-CBD) into the legal marketplace

Silver Spring, MD – The American Herbal Products Association (AHPA), the voice of the herbal products industry, celebrates the 10-year anniversary of its Cannabis Committee today. The Committee was established on March 10, 2010 to address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species, including hemp and hemp-derived cannabidiol (CBD).

AHPA submits comments to USDA on domestic hemp production program

January 30, 2020: Significant room for improvement in the hemp production Interim Final Rule and the subsequent Final Rule

In comments submitted to U.S. Department of Agriculture (USDA), Agricultural Marketing Service (AMS), AHPA requested numerous, significant revisions to the Interim Final Rule (IFR) that establishes a domestic hemp production program before a Final Rule is promulgated in 2021.
RSS

2021 Annual Fund Sponsors

    

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.